medroxyprogesterone acetate has been researched along with Cell Transformation, Neoplastic in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (16.67) | 18.7374 |
| 1990's | 4 (33.33) | 18.2507 |
| 2000's | 2 (16.67) | 29.6817 |
| 2010's | 4 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, FP; Chen, HY; Chien, MH; Huang, TS; Ng, YT | 1 |
| Blanco, MA; Bronson, RT; Chakrabarti, R; Chekmareva, M; Guo, F; Haffty, BG; Hua, Y; Kang, Y; Lu, X; Shen, M; Smith, HA; Wan, L; Wei, Y; Wu, H; Xing, Y; Yuan, M; Yuan, S | 1 |
| Abba, MC; Aldaz, CM; Gaddis, S; Kil, H; Lee, J; Lu, Y; Shen, J; Simper, MS; Takata, Y; Zhong, Y | 1 |
| Branstetter, D; Dougall, WC; Erwert, R; Gonzalez-Suarez, E; Jacob, AP; Jones, J; Miller, R; Pinkas, J; Roudier-Meyer, MP | 1 |
| Chen, Y; Rittling, SR | 1 |
| Itoh, J; Kajiwara, H; Matsui, N; Miyamoto, T; Murakami, M; Osamura, RY; Shinozuka, T; Yasuda, M | 1 |
| Balaña, ME; Charreau, EH; Elizalde, PV | 1 |
| Bush, TL; Espeland, MA; Greendale, GA; Johnson, SR; Judd, HL; Legault, C; Trabal, J; Wasilauskas, CH | 1 |
| Murphy, LC; Wong, MS | 1 |
| Charreau, EH; Elizalde, PV; Kordon, E; Lanari, C; Tezón, J | 1 |
| Miura, K; Nagasawa, H; Nakajima, K; Namiki, H; Niki, K; Noguchi, Y; Ohta, K | 1 |
| Aoki, M; Ishida, M; Nagasawa, H; Sakagami, N | 1 |
1 trial(s) available for medroxyprogesterone acetate and Cell Transformation, Neoplastic
| Article | Year |
|---|---|
Agreement in assessing endometrial pathology: the Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial.
Topics: Biopsy; Cell Transformation, Neoplastic; Double-Blind Method; Endometrial Neoplasms; Endometrium; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Observer Variation; Progesterone Congeners; Sensitivity and Specificity | 1998 |
11 other study(ies) available for medroxyprogesterone acetate and Cell Transformation, Neoplastic
| Article | Year |
|---|---|
Effects of estradiol and progestogens on human breast cells: regulation of sex steroid receptors.
Topics: Apoptosis; Breast Neoplasms; Caspase 3; Cell Proliferation; Cell Transformation, Neoplastic; Cyproterone Acetate; Estradiol; Estrogen Receptor alpha; Estrogen Receptor beta; Estrogens; Female; Humans; MCF-7 Cells; Medroxyprogesterone Acetate; Norethindrone; Norethindrone Acetate; Progesterone; Progestins; Receptors, Progesterone | 2013 |
MTDH-SND1 interaction is crucial for expansion and activity of tumor-initiating cells in diverse oncogene- and carcinogen-induced mammary tumors.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Breast Neoplasms; Cell Adhesion Molecules; Cell Line, Tumor; Cell Proliferation; Cell Transformation, Neoplastic; Cell Transformation, Viral; Endonucleases; Female; Gene Expression Regulation, Neoplastic; Genetic Predisposition to Disease; HEK293 Cells; Humans; Mammary Glands, Animal; Mammary Tumor Virus, Mouse; Medroxyprogesterone Acetate; Membrane Proteins; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Neoplasm Invasiveness; Neoplastic Stem Cells; Nuclear Proteins; Phenotype; Protein Binding; RNA Interference; RNA-Binding Proteins; Time Factors; Transfection; Tumor Cells, Cultured | 2014 |
DMBA induced mouse mammary tumors display high incidence of activating Pik3caH1047 and loss of function Pten mutations.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Cell Transformation, Neoplastic; Class I Phosphatidylinositol 3-Kinases; DNA Mutational Analysis; Exome Sequencing; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Mammary Neoplasms, Experimental; Medroxyprogesterone Acetate; Mice, Inbred C57BL; Mice, Inbred DBA; Mutation; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; RANK Ligand; Sequence Analysis, RNA; Time Factors; Transcriptome | 2016 |
RANK ligand mediates progestin-induced mammary epithelial proliferation and carcinogenesis.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Breast Neoplasms; Cell Proliferation; Cell Transformation, Neoplastic; Disease Models, Animal; Epithelial Cells; Female; Humans; Lung Neoplasms; Mammary Neoplasms, Experimental; Mammary Tumor Virus, Mouse; Medroxyprogesterone Acetate; Mice; Mice, Inbred C57BL; Mice, Transgenic; Neoplasm Invasiveness; Precancerous Conditions; Progesterone; Progestins; RANK Ligand; Receptor Activator of Nuclear Factor-kappa B | 2010 |
Novel murine mammary epithelial cell lines that form osteolytic bone metastases: effect of strain background on tumor homing.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antigens, Polyomavirus Transforming; Antineoplastic Agents, Hormonal; Bone Neoplasms; Carcinogens; Cell Transformation, Neoplastic; Epithelial Cells; Female; Genes, ras; Heart Ventricles; Humans; Keratins; Liver Neoplasms, Experimental; Male; Mammary Neoplasms, Experimental; Medroxyprogesterone Acetate; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Mice, Knockout; Neoplastic Cells, Circulating; Osteolysis; Osteopontin; Retroviridae; Sialoglycoproteins; Transfection; Tumor Cells, Cultured | 2003 |
Malignant transformation of atypical endometrial hyperplasia after progesterone therapy showing germ-cell tumor-like differentiation.
Topics: Adenocarcinoma; Adult; Alkaline Phosphatase; alpha-Fetoproteins; Biomarkers, Tumor; Cell Transformation, Neoplastic; Chorionic Gonadotropin; Endometrial Hyperplasia; Endometrial Neoplasms; Fatal Outcome; Female; Germinoma; GPI-Linked Proteins; Humans; Hysterectomy; Immunoenzyme Techniques; Isoenzymes; Loss of Heterozygosity; Medroxyprogesterone Acetate; Microsatellite Repeats | 2004 |
[Growth hormones and oncogenes in mammary adenocarcinomas induced by medroxyprogesterone acetate in BALB/c mice].
Topics: Adenocarcinoma; Animals; Cell Transformation, Neoplastic; Epidermal Growth Factor; Female; Growth Substances; Insulin-Like Growth Factor I; Insulin-Like Growth Factor II; Mammary Neoplasms, Experimental; Medroxyprogesterone Acetate; Mice; Mice, Inbred BALB C; Oncogenes; Receptors, Growth Factor; Transforming Growth Factor beta | 1997 |
Differential regulation of c-myc by progestins and antiestrogens in T-47D human breast cancer cells.
Topics: Breast Neoplasms; Cell Line; Cell Transformation, Neoplastic; Estrogen Antagonists; Female; Gene Expression Regulation, Neoplastic; Genes, myc; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Progestins; Proto-Oncogene Proteins c-myc; RNA, Messenger; Tamoxifen; Tumor Cells, Cultured | 1991 |
Transforming growth factor-beta activities in 'in vivo' lines of hormone-dependent and independent mammary adenocarcinomas induced by medroxyprogesterone acetate in BALB/c mice.
Topics: Adenocarcinoma; Animals; Cell Division; Cell Transformation, Neoplastic; Chromatography, High Pressure Liquid; DNA Replication; Drug Interactions; Epidermal Growth Factor; Fibroblasts; Gene Expression Regulation, Neoplastic; Insulin; Mammary Neoplasms, Experimental; Medroxyprogesterone; Medroxyprogesterone Acetate; Mice; Mice, Inbred BALB C; Neoplasm Proteins; Neoplasms, Hormone-Dependent; Rats; Transforming Growth Factor beta | 1990 |
Interrelationship between pituitary and ovarian hormones in normal and neoplastic growth of mammary glands of mice.
Topics: Animals; Cell Transformation, Neoplastic; DNA; DNA Replication; Estrogens; Female; Growth Hormone; Mammary Glands, Animal; Mammary Neoplasms, Experimental; Medroxyprogesterone; Medroxyprogesterone Acetate; Mice; Ovary; Precancerous Conditions; Progesterone; Prolactin | 1986 |
Medroxyprogesterone acetate enhances spontaneous mammary tumorigenesis and uterine adenomyosis in mice.
Topics: Animals; Cell Transformation, Neoplastic; Endometriosis; Female; Mammary Glands, Animal; Mammary Neoplasms, Experimental; Medroxyprogesterone; Medroxyprogesterone Acetate; Mice; Organ Size; Precancerous Conditions; Uterine Neoplasms | 1988 |